Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan

Abstract Introduction Despite many prostate cancer (PC) treatment options in Japan, physicians’ and patients’ preferences in metastatic castration-sensitive PC (mCSPC) and castration-resistant PC (CRPC) are unclear. Methods For this cross-sectional study, an online questionnaire survey based on the...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Takahiro Kimura, Noriko Takahashi, Keiko Asakawa, Atsushi Saito, Takeshi Mitomi, Takumi Lee, Mika Matsumura
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2025-02-01
Serija:	Oncology and Therapy
Teme:	Best–worst scaling Castration-resistant prostate cancer Metastatic castration-sensitive prostate cancer Patient Physician Treatment preference
Online dostop:	https://doi.org/10.1007/s40487-025-00326-6
Oznake:	Označite Brez oznak, prvi označite!